Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 2
2007 2
2009 2
2010 4
2011 3
2012 2
2013 2
2014 3
2015 4
2016 4
2017 9
2018 5
2019 5
2020 12
2021 16
2022 7
2023 5
2024 12
2025 11
2026 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

96 results

Results by year

Filters applied: . Clear all
Page 1
Reasons driving choice and clinical course of patients with CNS WHO grade 3 IDH mutant glioma receiving vorasidenib after surgery: a pilot experience.
Dipasquale A, Giordano P, Bosio A, Wijnenga MMJ, Giordano L, Losurdo A, Persico P, Padovan M, Viggiano A, Catapano G, Geurts M, Pessina F, Santoro A, Lombardi G, Simonelli M. Dipasquale A, et al. Among authors: simonelli m. J Neurooncol. 2026 Jan 28;176(3):186. doi: 10.1007/s11060-026-05439-0. J Neurooncol. 2026. PMID: 41604034
Diagnostic and predictive molecular biomarkers in brain tumors across the lifespan: an age-stratified consensus statement.
Mastronuzzi A, Franceschi E, D'Antonio F, Bennicelli E, Berzero G, Cella E, Filippi M, Lanzetta G, Marchioni E, Milanaccio C, Simonelli M, Bini P, Silvani A, Pace A. Mastronuzzi A, et al. Among authors: simonelli m. J Neurooncol. 2025 Nov 24;176(1):95. doi: 10.1007/s11060-025-05329-x. J Neurooncol. 2025. PMID: 41284071 Free PMC article. Review.
Beamion BCGC-1: phase Ib/II trial of zongertinib for advanced HER2-positive breast or gastroesophageal cancers.
Hurvitz S, Simonelli M, Yarza R, Berz D, Kitano S, Del Conte G, Acosta Eyzaguirre D, Doger de Speville Uribe BG, Maier D, Erzen D, Aykut Yazgili S, Curigliano G, Deng T, Yan M, Zhang Q, Wang X, Nakayama I, Shitara K. Hurvitz S, et al. Among authors: simonelli m. Future Oncol. 2025 Nov;21(26):3385-3393. doi: 10.1080/14796694.2025.2569553. Epub 2025 Oct 17. Future Oncol. 2025. PMID: 41108088 Free PMC article.
Case study: Successful full-course chemotherapy administration in a liver transplant recipient diagnosed with central nervous system World Health Organization Grade 2 IDH mutant/1p-19q co-deleted oligodendroglioma.
Dipasquale A, Losurdo A, Persico P, Aimola S, Fernandes B, Evangelista L, Simonelli M. Dipasquale A, et al. Among authors: simonelli m. Neurooncol Pract. 2025 Mar 22;12(5):922-927. doi: 10.1093/nop/npaf034. eCollection 2025 Oct. Neurooncol Pract. 2025. PMID: 41080208 Free PMC article.
Lenvatinib plus pembrolizumab for patients with previously treated select solid tumors: Results from the phase 2 LEAP-005 study recurrent glioblastoma cohort.
Rha SY, Castanon E, Gill S, Senellart H, Lopez J, Márquez-Rodas I, Victoria I, Kim TM, Lwin Z, Burger MC, Simonelli M, Cassier PA, Hendifar AE, Ascierto PA, Dutcus C, Okpara CE, Ghori R, Jin F, Groisberg R, Villanueva L. Rha SY, et al. Among authors: simonelli m. Cancer. 2025 Aug 15;131(16):e70015. doi: 10.1002/cncr.70015. Cancer. 2025. PMID: 40808295 Free PMC article. Clinical Trial.
96 results